Chemical formula: C₂₀H₂₄N₂O₂ Molecular mass: 324.417 g/mol PubChem compound: 441074
Quinidine interacts in the following cases:
There are no or limited amount of data from the use of quinidine in pregnant women. As this medicinal product may cause foetal harm, it is not recommended during pregnancy and in women of childbearing potential not using contraception.
Quinidine is excreted in human milk. A risk to the newborns/infants cannot be excluded. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from quinidine therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman.
In pre-clinical studies no effect on fertility was observed in male and female rats.
Quinidine has no or negligible influence on the ability to drive and use machines. Patients should be warned about the potential for CNS-related effects like somnolence, dizziness and syncope or impaired vision, and advised not to drive or operate machinery if these symptoms occur.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
